Literature DB >> 1728668

Unsuspected preexisting saphenous vein disease: an unrecognized cause of vein bypass failure.

T F Panetta1, M L Marin, F J Veith, J Goldsmith, R E Gordon, A M Jones, M L Schwartz, S K Gupta, K R Wengerter.   

Abstract

Our prior anecdotal experience with unsuspected preexisting saphenous vein disease prompted us to study its incidence, its relation to graft failure, and to identify techniques for its detection. Thick-walled, postphlebitic sclerotic occluded, postphlebitic sclerotic recanalized, calcified, and varicose vein lesions were detected in 63 (12%) of 513 infrainguinal vein bypasses. In 13 (2% to 5%) cases, severe saphenous vein disease precluded use of the vein. In the remaining 50 cases, the entire vein or a portion thereof, with minimal or unsuspected disease, was used for bypass. Early graft failures occurred in 10 (20%) of the 50 cases. The cumulative primary patency rate at 30 months for bypasses performed with diseased veins was 32%. This was significantly less than the 73% cumulative primary patency rate for bypasses with veins without detectable disease (p less than or equal to 0.001). Retrospective evaluation of preoperative duplex ultrasonography (n = 21) originally used to evaluate saphenous vein length and diameter correctly identified thick-walled, occluded, calcified, and varicose veins in 62% of cases. Intraoperative methods of vein evaluation included inspection, palpation, irrigation, catheter or valvulotome insertion to identify obstruction, and intraoperative arteriography. Histologic examination of diseased veins demonstrated a spectrum of disease with thickening of the intima and media, vein wall calcification, and luminal recanalization. We conclude that (1) unsuspected preexisting saphenous vein disease occurs in approximately 12% of cases and results in both early and late graft failures; (2) detection, in some cases, is possible with duplex ultrasonography and intraoperative techniques; and (3) diseased veins that are recanalized, calcified, or thick-walled should not be used if an alternative vein is available.

Entities:  

Mesh:

Year:  1992        PMID: 1728668

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  6 in total

1.  Perioperative use of eicosapentaenoic acid and patency of infrainguinal vein bypass: A retrospective chart review.

Authors:  Shinsuke Mii; Terutoshi Yamaoka; Daihiko Eguchi; Jin Okazaki; Kiyoshi Tanaka
Journal:  Curr Ther Res Clin Exp       Date:  2007-05

Review 2.  Vein quality in infrainguinal revascularisation: assessment by angioscopy and histology.

Authors:  Y G Wilson
Journal:  Ann R Coll Surg Engl       Date:  1998-01       Impact factor: 1.891

3.  Femoropopliteal Bypass with Varicose Greater Saphenous Vein.

Authors:  Yun Su Mun; Byung Sun Cho; Je-Ho Jang; Moon-Soo Lee; Oh Sang Kwon
Journal:  Int J Angiol       Date:  2015-05-25

4.  Vein factors that affect the outcome of femorodistal bypass.

Authors:  A H Davies
Journal:  Ann R Coll Surg Engl       Date:  1995-01       Impact factor: 1.891

5.  Prospective randomized controlled trial to analyze the effects of intermittent pneumatic compression on edema following autologous femoropopliteal bypass surgery.

Authors:  Alexander te Slaa; Dennis E J G J Dolmans; Gwan H Ho; Paul G H Mulder; Jan C H van der Waal; Hans G W de Groot; Lijckle van der Laan
Journal:  World J Surg       Date:  2011-02       Impact factor: 3.352

6.  Effect of preservation solution and distension pressure on saphenous vein's endothelium.

Authors:  Matheus Duarte Pimentel; José Glauco Lobo Filho; Heraldo Guedis Lobo Filho; Emílio de Castro Miguel; Sergimar Kennedy Pinheiro Paiva; João Igor Silva Matos; Matheus Augusto Mesquita Fernandes; Francisco Vagnaldo Fechine Jamacaru
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-08-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.